Dr. Len Neckers, Senior Investigator in CCR's Urologic Oncology Branch, takes you into his lab where he researches the role of chaperone proteins in signal transduction. Dr. Neckers studies the chaperone Hsp90, and has over the years developed Hsp90 inhibitors as novel anti-cancer agents. Watch and listen to Dr. Neckers' progress in developing the next generation of Hsp90 inhibitors to be used as powerful drugs in the fight against cancer.
A service of the National Cancer Institute
